Publications

Detailed Information

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Cited 41 time in Web of Science Cited 45 time in Scopus
Authors

Lee, Junghee; Jung, Hyun Boo; Ryu, Hoon

Issue Date
2009-11-30
Publisher
ELSEVIER SCIENCE BV
Citation
ADVANCED DRUG DELIVERY REVIEWS; Vol.61 14; 1316-1323
Keywords
NeuroprotectionAlzheimer`s diseaseParkinson`s diseaseTherapeuticsHuntington`s diseaseAmyotrophic lateral sclerosis
Abstract
Mitochondria are the power engine generating biochemical energy in the cell. Mitochondrial dysfunction and bioenergy deficiency is closely linked to the pathogenesis of neurodegenerative disorders. Mitochondria play a variety of roles by integrating extracellular signals and executing important intracellular events in neuronal survival and death. in this context, the regulation of mitochondrial function via therapeutic approaches may exert some salutary and neuroprotective mechanisms. Understanding the relationship of mitochondria-dependent pathogenesis may provide important pharmacological utility in the treatment of neurodegenerative conditions such as Alzheimer`s disease, amyotrophic lateral sclerosis, Huntington`s disease and Parkinson`s disease. Indeed, the modulation of mitochondrial pathways is rapidly emerging as a novel therapeutic target. This review focuses on how mitochondria are involved in neurodegeneration and what therapeutics are available to target mitochondrial pathways. (C) 2009 Elsevier B.V. All rights reserved.
ISSN
0169-409X
Language
English
URI
https://hdl.handle.net/10371/78197
DOI
https://doi.org/10.1016/j.addr.2009.07.016
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share